Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC63517 structure
    GC63517PD-1-IN-24
    CAS: 2360909-50-6
    纯度: >98.00%

    PD-1-IN-24 (compound 1) 是具有口服活性的 PD-1 的抑制剂。

  • GC63531 structure
    GC63531S65487 sulfate
    CAS: 2416937-01-2

    S65487 (VOB560) sulfate 是一种有效的选择性 Bcl-2 抑制剂。 S65487 sulfate 对 BCL-2 突变也有活性,例如 G101V 和 D103Y。S65487 sulfate 对 MCL-1,BFL-1 和 BCL-XL 的亲和力较差。S65487 sulfate 诱导细胞凋亡 (apoptosis) 并具有抗癌活性。

  • GC63592 structure
    GC63592LCS-1
    CAS: 41931-13-9
    纯度: >98.00%

    An inhibitor of SOD1

  • GC63604 structure
    GC63604Sparfosic acid
    CAS: 51321-79-0

    Sparfosic acid 是 DNA 抗代谢剂和天门冬氨酸氨甲酰转移酶 (aspartate transcarbamoyl transferase) 的有效抑制剂。Sparfosic acid 具有抗肿瘤活性。天冬氨酸氨甲酰转移酶催化第二步 de novo 嘧啶生物合成。

  • GC63709 structure
    GC63709SM-433 hydrochloride

    SM-433 hydrochlorid 是一种 Smac 模拟物,是一种凋亡抑制蛋白 (IAPs) 的抑制剂发挥作用。SM-433 hydrochlorid 表现出强结合亲和力 XIAP BIR3 蛋白,IC50 <1 μM (详细信息来自专利 WO2008128171A2)。

  • GC63769 structure
    GC63769PROTAC Bcl-xL degrader-2

    PROTAC Bcl-xL degrader-2 是一种基于 von Hippel-Lindau 配体的 Bcl-xL (Bcl-2 家族成员) 降解剂,IC50 为 0.6 nM。

  • GC63845 structure
    GC63845Eribulin-d3 mesylate

    Eribulin-d3 mesylate 是 Eribulin mesylate 的氘代物。Eribulin mesylate 是靶向微管 (microtubule) 的抗癌剂,可用于研究癌症。

  • GC63860 structure
    GC63860Rapanone
    CAS: 573-40-0
    纯度: >99.00%

    Rapanone是一种天然存在的具有优势螯合结构的羟基苯醌,具有广泛的生物活性,特别是其抗炎、驱虫和细胞毒性活性。

  • GC63870 structure
    GC63870SBP-0636457
    CAS: 1422180-49-1
    纯度: >98.00%

    SBP-0636457 (SB1-0636457) 是一种 SMAC 模拟物,是 IAP 的拮抗剂。SBP-0636457 以 0.27 μM 的 Ki 与 IAP 蛋白的 BIR 结构域结合。SBP-0636457 可用于实体瘤和血液系统癌症的研究。

  • GC63871 structure
    GC63871Echitamine chloride
    CAS: 6878-36-0
    纯度: >98.00%

    Echitamine chloride 是存在于 Alstonia 中的主要单萜吲哚生物碱,具有有效的抗肿瘤活性。Echitamine chloride 会诱导 DNA 片段化和细胞凋亡 (apoptosis)。Echitamine chloride 抑制胰腺脂肪酶 (pancreatic lipase),IC50 为 10.92 µM。

  • GC63902 structure
    GC63902Hematoporphyrin monomethyl ether
    CAS: 148471-91-4
    纯度: >95.00%

    Hematoporphyrin monomethyl ether 是第二代卟啉类光敏剂,具有形态单一、单线态氧产率高、选择性高、毒性低等特点,广泛应用于各种肿瘤的诊断和治疗,包括肺癌、膀胱癌,脑胶质瘤与焰色痣。

  • GC63914 structure
    GC63914Raptinal
    CAS: 1176-09-6
    纯度: >97.00%

    Raptinal 直接激活 caspase-3,可启动 caspase 依赖性的细胞凋亡内源性途径。Raptinal 能够通过直接激活效应 caspase-3来快速诱导癌细胞死亡,绕过启动子 caspase-8 和 caspase-9的激活。

  • GC63916 structure
    GC63916PROTAC-O4I2
    纯度: >98.00%

    PROTAC-O4I2是一种2-氨基噻唑衍生物,能够选择性降解SF3B1并以CRBN依赖的方式诱导细胞凋亡(IC 50 = 0.244μM)。

  • GC63932 structure
    GC63932Amsilarotene
    CAS: 125973-56-0
    纯度: >99.00%

    Amsilarotene (TAC-101; Am 555S) 是一种具有口服活性的合成类视黄醇,对视黄酸受体 α (RAR-α) 具有选择性亲和力,对 RAR-α 和 RAR-β 的 Ki 值为 2.4 nM 和 400 nM。Amsilarotene 诱导人胃癌、肝细胞癌和卵巢癌细胞的凋亡 (apoptotic)。Amsilarotene 可用于癌症研究。

  • GC63933 structure
    GC63933S-Allylmercaptocysteine
    CAS: 2281-22-3
    纯度: >95.00%

    S-allylmercaptocysteine 是一种从大蒜中提取的有机硫化合物,对各种肺部疾病具有抗炎和抗氧化作用。S-allylmercaptocysteine 通过多种途径发挥抗癌作用,如通过 TGF-β 信号通路诱导癌细胞凋亡 (apoptosis),或通过降低 NF-κb 活性和上调 Nrf2 来达到抗炎和抗氧化的作用。

  • GC63934 structure
    GC63934Karanjin
    CAS: 521-88-0

    Karanjin 是 Fordia cauliflora 中主要的活性呋喃黄酮醇成分。Karanjin 通过提高 AMPK 的方式诱导骨骼肌细胞 GLUT4 易位。Karanjin 可通过细胞周期阻滞诱导癌细胞死亡,促进细胞凋亡。

  • GC63941 structure
    GC63941&#945;-Solanine
    CAS: 20562-02-1

    α-solanine 是马铃薯中的一种生物活性成分,是主要的甾体类生物碱之一,可抑制癌细胞的生长并诱导其凋亡 (apoptosis)。

  • GC63942 structure
    GC63942Oxysophoridine
    CAS: 54809-74-4
    纯度: >98.00%

    Oxysophoridine (Sophoridine N-oxide) 是从 Sophora alopecuroides Linn 中提取的具有生物活性生物碱。Oxysophoridine (Sophoridine N-oxide) 具有抗发炎,抗氧化应激和抗凋亡的作用。

  • GC63958 structure
    GC639586&#945;-Hydroxy Paclitaxel-d5
    CAS: 1315376-90-9

    6α-Hydroxy Paclitaxel-d5 是 6α-Hydroxy paclitaxel 的氘代物。6α-Hydroxy paclitaxel 是紫杉醇的初级代谢物。6α-Hydroxy paclitaxel 对有机阴离子转运多肽 1B1/SLCO1B1 (OATP1B1) 具有与紫杉醇相似的时间依赖性抑制效力,但它对 OATP1B3 不具有时间依赖性作用。6α-Hydroxy paclitaxel 可用于癌症研究。

  • GC63967 structure
    GC63967Cycleanine
    CAS: 518-94-5
    纯度: >99.00%

    An alkaloid with anticancer and antimalarial activities

  • GC63972 structure
    GC639725,7-Dimethoxyflavanone
    CAS: 1277188-85-8
    纯度: >99.00%

    5,7-Dimethoxyflavanone 在 Ames 试验中对鼠伤寒 TA100 和 TA98 菌株的 MeIQ 诱变表现出较强的抗诱变活性,也能显著且剂量依赖性地抑制炎症介质:一氧化氮(NO)和细胞因子(TNF-α和IL-12)。

  • GC63979 structure
    GC63979Ro24-7429
    CAS: 139339-45-0

    Ro24-7429 是一种有效且具有口服活性的 HIV-1 反式激活蛋白 Tat 拮抗剂。Ro24-7429 也是 RUNX1 抑制剂。Ro24-7429 具有抗 HIV、抗纤维化和抗炎作用。

  • GC63984 structure
    GC63984PD-L1-IN-1
    CAS: 2767424-13-3
    纯度: >99.50%

    PD-L1-IN-1 是一种有效的 PD-L1 抑制剂,IC50 为 115 nM。PD-L1-IN-1与PD-L1蛋白强结合,并在表达 PD-L1 的癌细胞(PC9 和 HCC827 细胞)和外周血单核细胞的共同培养中激发 PD-L1 蛋白,增强后者的抗肿瘤免疫活性。PD-L1-IN-1 显著增加了干扰素 γ 的释放和癌细胞的凋亡诱导,对健康细胞的细胞毒性较低。

  • GC63986 structure
    GC63986VAS 3947
    CAS: 869853-70-3
    纯度: >99.00%

    VAS 3947 是一种特异的 NADPH 氧化酶 (NOX) 抑制剂,具有强大的抗血小板作用。VAS 3947 通过 UPR 激活,主要由于蛋白质聚集和错误折叠,独立于抗 NOX 活性诱导细胞凋亡 (apoptosis)。